Aaron Berez

Biography

  Dr. Berez is an acknowledged international thought leader in interventional radiology, with a career in medicine, innovation and commercialization. He was a co-founder and CEO of Chestnut Medical Technologies, Inc. where he led the development of innovative devices for Interventional Neuroradiology, including the Pipeline Embolization Device© (PED).  The PED received PMA approval from the FDA in April 2011 and was hailed as one of the top ten medical devices for 2012 by the Cleveland Clinic.  Chestnut Medical was acquired by eV3 Inc. for more than $150 million in June 2009. Before co-founding Chestnut he served as the VP of Clinical Affairs at Smart Therapeutics, Inc. where he helped develop new intracranial stents devices for the treatment of aneurysms and intracranial atherosclerosis. He had previously served as the Clinical Director at Endovasix and developed novel devices for the treatment of stroke. Dr. Berez was an investor in Sapheon, Inc. where he served as a director until the company was acquired by Covidien in 2014. A graduate of the Georgetown University School of Medicine where he received his MD degree, Dr Berez completed post-graduate training at UCSF/Mt. Zion in Internal Medicine, and Stanford University in Radiology and Neuroradiology, where he served as a Clinical Instructor in the Department of Radiology from 1997-2000. Dr. Berez currently leads Alembic, LLC, a medical device company in Mountain View, CA developing novel medical devices to treat unmet needs.

Research Interest

 Business